The Amgen Safety Net Foundation is a nonprofit patient assistance program that helps qualifying uninsured patients access Amgen medicines at no cost. Products supported by the Amgen Safety Net Foundation covers Aranesp® (darbepoetin), EPOGEN® (epoetin) for dialysis use only, Neulasta® (pegfilgrastim), NEUPOGEN® (filgrastim), Nplate® (romiplostim), Prolia® (denosumab) injection, Sensipar® (cinacalcet), Vectibix® (panitumumab) injection, and XGEVA® (denosumab).

Therapies Offered

  • Aranesp® (darbepoetin alfa)

  • BLINCYTO® (blinatumomab) for injection

  • Corlanor® (ivabradine) tablets

  • Enbrel® (etanercept)

  • EPOGEN® (EPOETIN ALFA) for dialysis use only

  • IMLYGIC® (talimogene laherparepvec) suspension for injection

  • Kyprolis® (carfilzomib) for injection

  • Neulasta Disposal Container

  • Neulasta® (pegfilgrastim)

  • Neupogen®

  • Nplate® (romiplostim)

  • Parsabiv™

  • Prolia® (denosumab) injection for bone health

  • Prolia® (denosumab) injection for bone health and oncology

  • Repatha Disposal Container

  • Repatha® (evolocumab)

  • Sensipar® (cinacalcet)

  • Vectibix® (panitumumab) injection

  • XGEVA® (denosumab)